Neuroprotection in the peripheral nervous system: Rationale for more effective therapies

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Most peripheral neuropathies are length dependent and result in distal axonal degeneration rather than loss of neuronal cell bodies. Available therapies for axonal peripheral neuropathies are designed to control painful symptoms and not to treat the underlying axonal degeneration. Many neuroprotective therapies are being developed, primarily for central nervous system disorders such as stroke or multiple sclerosis. However, strategies with the purpose of promoting survival of injured neurons (ie, preventing cell death) may not be applicable in many peripheral nervous system illnesses when the primary pathologic disorder that leads to symptoms is distal axonal degeneration. Neuronal cell death, if it occurs, is often a late event and may be untreatable in the near future. In contrast, distal axonal degeneration is an early event that may be amenable to treatment. Mechanistic studies that examine the axonglia interaction and axonal biology are likely to yield novel therapeutic targets for peripheral neuropathies.

Original languageEnglish (US)
Pages (from-to)1681-1685
Number of pages5
JournalArchives of neurology
Issue number12
StatePublished - Dec 2006

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology


Dive into the research topics of 'Neuroprotection in the peripheral nervous system: Rationale for more effective therapies'. Together they form a unique fingerprint.

Cite this